Fw: (LML) New publications on leprosy. October, 2020

Leprosy Mailing List – October 7,  2020   Ref.:  (LML) New publications on leprosy. October, 2020   From:  Anniek Akerboom, Amsterdam, the Netherlands     Dear colleagues, NLR India launched the innovative research project Stop the Transmission of Leprosy! On October 2nd, the first enhanced dose of post-exposure chemoprophylaxis (PEP++) was given to close contacts of leprosy patients in the two study districts Chandauli and Fatehpur. We would like to congratulate all parties involved with this great accomplishment and wish them good luck in continuing this project. Read the full news article here. This month the WHO hosts two interesting NTD webinars. Join the following webinars on October 7th What role does disability, stigma and mental health play in achieving the NTD road map targets? and October 21st How do we tackle the skin NTDs to reach the 2030 NTD road map targets? Infolep aims to increase its accessibility by sharing publications in multiple languages. If you come across a key publication of which you need a translated version, kindly inform us and we will try to acquire a translated version through our partners. This monthly review consists of interesting publications on, among others, COVID-19, stigma, global epidemiology, mental wellbeing, PEP and prevention of disabilities. Enjoy the read! Feel free to contact me to receive full-text versions if these cannot be found through the Infolep portal. Also, I would be happy to assist you with literature searches. Warm regards, Anniek Akerboom Infolep Coordinator www.leprosy-information.org a.akerboom@infolep.org

 

 

Highlighted

 

 

Global leprosy update, 2019: time to step-up prevention initiatives World Health Organization. Weekly epidemiological record. 2020; 95 (36) : 417–440. Learn more

 

 

Leprosy & COVID-19

 

 

From leprosy to COVID-19, how stigma makes it harder to fight epidemics Chandrashekhar V. American Association for the Advancement of Science. 2020;  Learn more Clinical Characteristics and Outcomes in Patients with COVID-2019 and Leprosy. Santos V, Quintans-Júnior L, Barboza W, et al. JEADV. 2020;  Learn more Practical Approaches to Implementing WHO Guidance for NTD Programs in the Context of COVID-19: Mass Drug Administration USAID. 2020;  Learn more

 

 

New publications

 

 

Autochthonous leprosy in Spain: Has the transmission of Mycobacterium leprae stopped? Suárez-García I, Gómez-Barroso D, Fine P. PLoS neglected tropical diseases. 2020; 14 (9) : e0008611.  Learn more Psychometric assessment of the EMIC Stigma Scale for Brazilians affected by leprosy. Morgado F, da Silveira E, Nascimento L, et al. PloS one. 2020; 15 (9) : e0239186.  Learn more Depression and mental wellbeing in people affected by leprosy in southern Nepal van Dorst MMAR, van Netten WJ, Waltz MM, et al. Global Health Action. Informa UK Limited. 2020; 13 (1) : 1815275.  Learn more Activity limitation and social participation restriction among leprosy patients in Boru Meda Hospital, Amhara Region, Ethiopia. Abdela S, van Henten S, Abegaz S, et al. PLoS neglected tropical diseases. 2020; 14 (9) : e0008702.  Learn more Disease experiences of female patients with Hansen's disease residing in settlement in Korea. Jung H, Yang Y. International journal for equity in health. 2020; 19 (1) : 144.  Learn more Experience of Persons Affected by Leprosy in Facing Psychosocial Problems: A Qualitative Method Yusuf A, Aditya RS, Yunitasari E, et al. Systematic Reviews in Pharmacy. 2020; 11 (7) : 219-223.  Learn more QoL of ex-leprosy patients' children in Vietnam Watanabe H, Tuan Anh V, Cong Ai H, et al. Japanese Journal of Leprosy. Japanese Leprosy Association. 2020; 89 (1) : 1-11.  Learn more How stigmatizing disease—from COVID-19 to HIV—creates a vicious cycle of sickness Goldberg J, Pasztor A, Chandrashekhar V. American Association for the Advancement of Science. 2020;  Watch the video Evaluation of ocular involvement in patients with Hansen's disease. Pavezzi P, Prado R, Filho P, et al. PLoS neglected tropical diseases. 2020; 14 (9) : e0008585.  Learn more Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy. Lenz S, Collins J, Ray N, et al. PLoS neglected tropical diseases. 2020; 14 (9) : e0008583.  Learn more Prevention of physical disabilities due to leprosy in Brazil: a historic analysis. Santos A, Ignotti E. Ciencia & saude coletiva. 2020; 25 (10) : 3731-3744.  Learn more Leprosy in Brazil in the 21st century: analysis of epidemiological and operational indicators using inflection point regression Souza CDFD, Paiva JPSD, Leal TC, et al. Anais Brasileiros de Dermatologia. Elsevier BV. 2020;  Learn more Leprosy transmission in endemic and non-endemic areas based on the profile of antibody response of PGL-1 and PCR detection of DNA from nasal swab among healthy children of East Java, Indonesia. Adriaty D, Sp C, Iswahyudi I, et al. Infectious disease reports. 2020; 12 (Suppl 1) : 8748.  Learn more Detection of HLA-B 13:01 gene among Dapsone hypersensitivity patients of leprosy in Papua Ethnics group using sequence based typing and qPCR rapid detection Krismawati H, Maladan Y, Rohman MF. THE 6TH INTERNATIONAL CONFERENCE ON BIOLOGICAL SCIENCE ICBS 2019: "Biodiversity as a Cornerstone for Embracing Future Humanity". AIP Publishing. 2020;  Learn more Elevated IL-6R on CD4 T cells promotes IL-6 driven Th17 cell responses in patients with T1R leprosy reactions. Saini C, Srivastava R, Tarique M, et al. Scientific reports. 2020; 10 (1) : 15143.  Learn more Ofloxacin-Containing Multidrug Therapy in Ambulatory Leprosy Patients: A Case Series. Faust L, Klowak M, MacRae C, et al. Journal of cutaneous medicine and surgery. 2020; Learn more Lazarine leprosy: A unique phenomenon of leprosy. Wankhade V, Shah V, Singh R, et al. International journal of mycobacteriology. 2020; 9 (3) : 329-331.  Learn more The First Report of Diversity Analyses of Skin Microbiome in Indonesian Leprosy Patient Gunawan H, Achdiat PA, Suwarsa O, et al. Research Square. 2020;  Learn more

 

 

Disclaimer

 

 

Some articles contain stigmatised wording. Please note that Infolep disapproves any stigmatising language. However, we aim to enable access to all relevant publications and want to emphasize that we are not responsible for the content of these publications. We inform journals when we notice stigmatising language in one of their articles and propose alternative wording.

 

 

Share   Retweet   Forward

 

 

Websites & Services

 

 

Info Hansen - A innovative hub for knowledge sharing about Hansen's Disease https://www.infohansen.org/ ALLF - Official website of the Association des Léprologues de Langue Française https://allf.medicalistes.fr/ LML - Leprosy Mailing List - a free moderated email list that allows all persons interested in this theme to share ideas, information, experiences, and questions. https://groups.google.com/forum/#!forum/leprosymailinglist InfoNTD - Information on cross-cutting issues in Neglected Tropical Diseases (NTDs) https://www.infontd.org/

 

 

Newsletters & Journals

 

 

ILEP newsletter archive: https://ilepfederation.org/news-events/#archive   GPZL newsletter archive: https://zeroleprosy.org/newsletter-archive/ Hansenologia Internationalis: http://www.ilsl.br/revista/atual.php Indian Journal of Leprosy: http://www.ijl.org.in/index.html Leprosy Review: https://leprosyreview.org/ Leprosy Review Repository (1928-2001): http://leprev.ilsl.br/arquivo.php

 

 

GDPR & the Infolep newsletter

 

 

New EU data protection regulations came into force on 25 May 2018. We have been reviewing our practices with regard to the GDPR, including our privacy statement and mailing list. Infolep sends out monthly e-mails to its subscribers with an overview of recent publications on leprosy. The purpose of this activity is to keep subscribers up to date. Infolep will only process the data we have (names, email addresses) for the purpose of sending you the newsletter. We take your security seriously and will never share your contact details with anyone else. We hope the content from the Infolep newsletter is useful to you, but you can update your preferences or unsubscribe from this list at any time.

 

 

Infolep   Infolep portal   Connect   Follow us

 

---

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/72116ef9-62c3-41bc-b21d-119ed010fda1o%40googlegroups.com.